IndiaTickerLatest filing: Concord Drugs Ltd - 538965 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
ObservedCompany dossier
Concord Drugs
BSE:CONCORD · ISIN INE858L01010
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Concord Drugs
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 54.39% and public 45.61% as of 31 Mar 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Concord Drugs Ltd - 538965 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Concord Drugs Ltd - 538965 - Closure of Trading Window
BSE · exchange filing
Observed
Source filing Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · financial results
Observed
Source filing Concord Drugs Ltd - 538965 - Compliances-Reg.24(A)-Annual Secretarial Compliance
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →31 Mar 2026
- Promoter group
- 54.39%
- Public
- 45.61%
- Employee trust
- N/A
Observed BSE shareholding XBRL